Letter to the Editor Regarding “Epstein-Barr Virus and COVID-19 Induced Systemic Inflammatory Response Syndrome and Guillain-Barré Syndrome - A Novel Case Report”

Article Sidebar

PDF PDF (Português (Brasil))
Published: Jan 6, 2026
DOI: https://doi.org/10.52600/2763-583X.bjcr.2026.6.1.bjcr149
Keywords:
Guillain-Barré Syndrome, Epstein-Barr Virus Infections, COVID-19, Systemic Inflammatory Response Syndrome, Causality

Main Article Content

Rafael Gomes de Melo D'Elia
Hospital das Clínicas, Faculty of Medicine, University of São Paulo (FMUSP)
Angélica Saiuri de Aurélio Penteado
Hospital das Clínicas, Faculty of Medicine, University of São Paulo (FMUSP)
https://orcid.org/0000-0001-5870-1828

Article Details

How to Cite
D’Elia, R. G. de M., & Penteado, A. S. de A. (2026). Letter to the Editor Regarding “Epstein-Barr Virus and COVID-19 Induced Systemic Inflammatory Response Syndrome and Guillain-Barré Syndrome - A Novel Case Report”. Brazilian Journal of Case Reports, 6(1), bjcr149. https://doi.org/10.52600/2763-583X.bjcr.2026.6.1.bjcr149
Issue
Vol. 6 No. 1 (2026): January/December - 2026
Section
Letter to Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their articles and grant the journal the right of first publication under the Creative Commons Attribution (CC BY) license, which allows others to share and adapt the work with proper attribution.

Author Biographies

Rafael Gomes de Melo D'Elia, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (FMUSP)

Hospital das Clínicas, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.

Angélica Saiuri de Aurélio Penteado, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (FMUSP)

Hospital das Clínicas, Faculty of Medicine, University of São Paulo (FMUSP), São Paulo, Brazil.

References

Chakraborty S, Rahaman M, Dey P, Purkait S, Sengupta S, Mandal A, Bhaumik S, Ramasubban S. Epstein-Barr virus and COVID-19–induced systemic inflammatory response syndrome and Guillain-Barré syndrome: a novel case report. Braz J Case Rep. 2026;6(1):bjcr140. doi:10.52600/2763-583X.bjcr.2026.6.1.bjcr140.

Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 Nov 5;366(9497):1653–1666. doi:10.1016/S0140-6736(05)67665-9. PMID:16271648.

Lunn MP, Carr AC, Keddie S, Pakpoor J, Pipis M, Willison HJ. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry; ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome; unclear as-sociation between COVID-19 and Guillain-Barré syndrome; currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 Jun 22;144(5):e47. doi:10.1093/brain/awab070. PMID:33822006; PMCID:PMC8083496.

Uncini A, Vallat JM, Jacobs BC. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of the pandemic. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1105–1110. doi:10.1136/jnnp-2020-324491. Epub 2020 Aug 27. PMID:32855289.